527 related articles for article (PubMed ID: 18564009)
1. Hepatitis A vaccines.
Nothdurft HD
Expert Rev Vaccines; 2008 Jul; 7(5):535-45. PubMed ID: 18564009
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis A vaccines and the elderly.
Genton B; D'Acremont V; Furrer HJ; Hatz C; Louis Loutan
Travel Med Infect Dis; 2006 Dec; 4(6):303-12. PubMed ID: 17098625
[TBL] [Abstract][Full Text] [Related]
3. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines.
Bryan JP; Nelson M
Arch Intern Med; 1994 Mar; 154(6):663-8. PubMed ID: 8129500
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis a in Korea: epidemiological shift and call for vaccine strategy.
Lee D; Cho YA; Park Y; Hwang JH; Kim JW; Kim NY; Lee DH; Lee W; Jeong SH
Intervirology; 2008; 51(2):70-4. PubMed ID: 18434743
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN
Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060
[TBL] [Abstract][Full Text] [Related]
6. Vaccination against hepatitis A virus may not be required for schoolchildren in northern India: results of a seroepidemiological survey.
Batra Y; Bhatkal B; Ojha B; Kaur K; Saraya A; Panda SK; Acharya SK
Bull World Health Organ; 2002; 80(9):728-31. PubMed ID: 12378291
[TBL] [Abstract][Full Text] [Related]
7. Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults.
Van Herck K; Leroux-Roels G; Van Damme P; Srinivasa K; Hoet B
Travel Med Infect Dis; 2007 May; 5(3):171-5. PubMed ID: 17448944
[TBL] [Abstract][Full Text] [Related]
8. [Vaccination against hepatitis A].
Balli F; Di Biase AR; Viola L
Pediatr Med Chir; 1996; 18(3):259-62. PubMed ID: 8966125
[TBL] [Abstract][Full Text] [Related]
9. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination.
Hussain Z; Das BC; Husain SA; Murthy NS; Kar P
J Gastroenterol Hepatol; 2006 Apr; 21(4):689-93. PubMed ID: 16677154
[TBL] [Abstract][Full Text] [Related]
10. Increasing incidence of hepatitis A in Korean adults.
Kim YJ; Lee HS
Intervirology; 2010; 53(1):10-4. PubMed ID: 20068335
[TBL] [Abstract][Full Text] [Related]
11. Vaccination strategies against hepatitis A in travelers older than 40 years: an economic evaluation.
Costas L; Vilella A; Trilla A; Serrano B; Vera I; Roldán M; Sancho MP; Bayas JM; Gascón J; Costa J
J Travel Med; 2009; 16(5):344-8. PubMed ID: 19796106
[TBL] [Abstract][Full Text] [Related]
12. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
[TBL] [Abstract][Full Text] [Related]
13. Vaccination of newborns against hepatitis A in the presence of maternally derived antibodies.
Vidor E
J Comp Pathol; 2007 Jul; 137 Suppl 1():S42-5. PubMed ID: 17555761
[TBL] [Abstract][Full Text] [Related]
14. Epidemiologic shift in the prevalence of Hepatitis A virus in Saudi Arabia: a case for routine Hepatitis A vaccination.
Almuneef MA; Memish ZA; Balkhy HH; Qahtani M; Alotaibi B; Hajeer A; Qasim L; Al Knawy B
Vaccine; 2006 Jul; 24(27-28):5599-603. PubMed ID: 16757065
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly.
D'Acremont V; Herzog C; Genton B
J Travel Med; 2006; 13(2):78-83. PubMed ID: 16553593
[TBL] [Abstract][Full Text] [Related]
16. Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands).
Postma MJ; Bos JM; Beutels P; Schilthuis H; van den Hoek JA
Vaccine; 2004 May; 22(15-16):1862-7. PubMed ID: 15121296
[TBL] [Abstract][Full Text] [Related]
17. A review of the long-term protection after hepatitis A and B vaccination.
Van Damme P; Van Herck K
Travel Med Infect Dis; 2007 Mar; 5(2):79-84. PubMed ID: 17298912
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and factors associated with self-reported vaccination rates among US adults at high risk of vaccine-preventable hepatitis.
Chen H; Cantrell CR
Curr Med Res Opin; 2006 Dec; 22(12):2489-96. PubMed ID: 17257463
[TBL] [Abstract][Full Text] [Related]
19. A dynamic model for assessing universal Hepatitis A vaccination in Canada.
Bauch CT; Rao AS; Pham BZ; Krahn M; Gilca V; Duval B; Chen MH; Tricco AC
Vaccine; 2007 Feb; 25(10):1719-26. PubMed ID: 17229493
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis A seroprevalence in children and adults in Kiev City, Ukraine.
Moisseeva AV; Marichev IL; Biloschitchkay NA; Pavlenko KI; Novik LV; Kovinko LV; Lyabis OI; Houillon G; Rasuli AM
J Viral Hepat; 2008 Oct; 15 Suppl 2():43-6. PubMed ID: 18837833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
